Manuel Joaquim Lopes Vaz da Silva


AuthID: R-000-A5F

Confirmed Publications: 72



41
TITLE: Bioavailability and bioequivalence of two enteric-coated formulations of omeprazole in fasting and fed conditions  Full Text
AUTHORS: Vaz da Silva, M ; Loureiro, AI; Nunes, T; Maia, J; Tavares, S; Falcao, A ; Silveira, P; Almeida, L; Soares da Silva, P ;
PUBLISHED: 2005, SOURCE: CLINICAL DRUG INVESTIGATION, VOLUME: 25, ISSUE: 6
INDEXED IN: Scopus WOS CrossRef: 23
IN MY: ORCID | CIÊNCIAVITAE
42
TITLE: Effect of food on the pharmacokinetic profile of eslicarbazepine acetate (BIA 2-093)  Full Text
AUTHORS: Maia, J; Vaz Da Silva, M ; Almeida, L; Falcao, A; Silveira, P; Guimaraes, S; Graziela, P; Soares Da Silva, P ;
PUBLISHED: 2005, SOURCE: Drugs in R and D, VOLUME: 6, ISSUE: 4
INDEXED IN: Scopus CrossRef: 43
IN MY: ORCID | CIÊNCIAVITAE
43
44
TITLE: Pharmacokinetic-pharmacodynamic interaction between BIA 3-202, a novel COMT inhibitor, and levodopa/carbidopa
AUTHORS: Almeida, L; Vaz da Silva, M ; Silveira, P; Falcao, A ; Maia, J; Loureiro, A; Torrao, L; Machado, R; Wright, L; Soares da Silva, P ;
PUBLISHED: 2004, SOURCE: CLINICAL NEUROPHARMACOLOGY, VOLUME: 27, ISSUE: 1
INDEXED IN: Scopus WOS CrossRef: 14
IN MY: ORCID | CIÊNCIAVITAE
45
46
TITLE: The endothelin system and heart failure: A new potential therapeutic target [Sistema da endotelina e insuficiência cardíaca: Um potencial alvo terapêutico]
AUTHORS: Vaz Da Silva, M ; Abreu Lima, C;
PUBLISHED: 2004, SOURCE: Revista Portuguesa de Cardiologia, VOLUME: 23, ISSUE: SUPPL. 2
INDEXED IN: Scopus
IN MY: ORCID | CIÊNCIAVITAE
47
TITLE: Pharmacokinetic-pharmacodynamic interaction between BIA 3-202, a novel COMT inhibitor, and levodopa/benserazide  Full Text
AUTHORS: Silveira, P; Vaz da Silva, M ; Almeida, L; Maia, J; Falcao, A ; Loureiro, A; Torrao, L; Machado, R; Wright, L; Soares da Silva, P ;
PUBLISHED: 2003, SOURCE: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, VOLUME: 59, ISSUE: 8-9
INDEXED IN: Scopus WOS CrossRef: 21
IN MY: ORCID | CIÊNCIAVITAE
48
TITLE: Psychomotor effects of mexazolam vs placebo in healthy volunteers  Full Text
AUTHORS: Silveira, P; Vaz Da Silva, M ; Dolgner, A; Almeida, L;
PUBLISHED: 2002, SOURCE: CLINICAL DRUG INVESTIGATION, VOLUME: 22, ISSUE: 10
INDEXED IN: Scopus WOS CrossRef: 7
IN MY: ORCID | CIÊNCIAVITAE
49
TITLE: Mexazolam and Alprazolam in the Treatment of Generalised Anxiety Disorder. A Double-Blind, Randomised Clinical Trial  Full Text
AUTHORS: Adriano Vaz-Serra; Maria Luisa Figueira; Alberto Bessa-Peixoto; Hor??cio Firmino; Rodolfo Albuquerque; Cristina Paz; Ana Dolgner; Manuel Vaz-Silva ; Luis Almeida;
PUBLISHED: 2001, SOURCE: Clinical Drug Investigation, VOLUME: 21, ISSUE: 4
INDEXED IN: CrossRef: 10
IN MY: ORCID
50
TITLE: Mexazolam and alprazolam in the treatment of generalised anxiety disorder - A double-blind, randomised clinical trial
AUTHORS: Vaz Serra, A; Figueira, ML; Bessa Peixoto, A; Firmino, H; Albuquerque, R; Paz, C; Dolgner, A; Vaz Silva, M ; Almeida, L;
PUBLISHED: 2001, SOURCE: CLINICAL DRUG INVESTIGATION, VOLUME: 21, ISSUE: 4
INDEXED IN: Scopus WOS
IN MY: ORCID
Page 5 of 8. Total results: 72.

A place for researchers and their institutions

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service